Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene-related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1].
Molecular Weight:
(145.5 kDa)
Purity:
98.88
CAS Number:
[1582205-90-0]
Target:
CGRP Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted